Senhwa Biosciences, Inc. @senhwabio

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses. senhwabio.com TAIPEI and San Diego, CA Joined July 2014
  • Tweets
    23
  • Followers
    47
  • Following
    2
  • Likes
    4